Skip to main content

Roche Holdings Ltd ADR(RHHBY)
OTC US

Today's Change
Delayed Last Update
Volume

Landmark Alzheimer's Prevention Trial Unable to Show Significantly Slower Cognitive Decline in Inherited Form of Disease

PR Newswire - Thu Jun 16, 12:05AM CDT

Groundbreaking Colombian study will still have major impact on Alzheimer's prevention research

PHOENIX, June 16, 2022 /PRNewswire/ -- A precedent-setting prevention trial in Colombia has found that the investigational medicine crenezumab did not slow or prevent decline in cognition or memory for cognitively healthy people with a rare genetic mutation that causes early-onset Autosomal Dominant Alzheimer's Disease (ADAD).

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.